Clinical evaluation consultation procedure for certain class III and class IIb devices
1. In addition to the procedures applicable pursuant to Article 52, a notified body shall also follow the procedure regarding clinical evaluation consultation as specified in Section 5.1 of Annex IX or as referred to in Section 6 of Annex X, as applicable, when performing a conformity assessment of the following devices:
|(a)||class III implantable devices, and|
|(b)||class IIb active devices intended to administer and/or remove a |
medicinal product, as referred to in Section 6.4 of Annex VIII (Rule
2. The procedure referred to in paragraph 1 shall not be required for the devices referred to therein:
|(a)||in the case of renewal of a certificate issued under this Regulation;|
|(b)||where the device has been designed by modifying a device already marketed by the same manufacturer for the same intended |
purpose, provided that the manufacturer has demonstrated to the
satisfaction of the notified body that the modifications do not
adversely affect the benefit-risk ratio of the device; or
|(c)||where the principles of the clinical evaluation of the device type or |
category have been addressed in a CS referred to in Article 9 and the notified body confirms that the clinical evaluation of the
manufacturer for this device is in compliance with the relevant CS
for clinical evaluation of that kind of device.
3. The notified body shall notify the competent authorities, the authority responsible for notified bodies and the Commission through the electronic system referred to in Article 57 of whether or not the procedure referred to in paragraph 1 of this Article is to be applied. That notification shall be accompanied by the clinical evaluation assessment report.
4. The Commission shall draw up an annual overview of devices which have been subject to the procedure specified in Section 5.1 of Annex IX and referred to in Section 6 of Annex X. The annual overview shall include the notifications in accordance with paragraph 3 of this Article and point (e) of Section 5.1 of Annex IX and a listing of the cases where the notified body did not follow the advice from the expert panel. The Commission shall submit this overview to the European Parliament, to the Council and to the MDCG.
5. The Commission shall by 27 May 2025 draw up a report on the operation of this Article and submit it to the European Parliament and to the Council. The report shall take into account the annual overviews and any available relevant recommendations from the MDCG. On the basis of that report the Commission shall, if appropriate, make proposals for amendments to this Regulation.